Oct 10, 2022

Ochre Bio raises $30M Series A financing for the development of RNA therapies for chronic liver diseases

Recent news

BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
BY BUILDERS
FOR BUILDERS
No interactions or Javascript Involved